Chlamydia Diagnosis: Tests and Methods Used to Detect Chlamydia Infection

  • Pooja SinghMasters of Pharmacy (M.Pharm.), Panjab University, Chandigarh (India)
  • Taniya JoseMaster of Engineering - MEng, Biomedical Engineering, University of Glasgow

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative

Introduction

Sexually transmitted infections (STIs) like chlamydia trachomatis can be very harmful to your health. Many people don't receive treatment because they appear asymptomatic, which lets the infection grow. If not treated, it can lead to pelvic inflammatory disease (PID), ectopic pregnancies, urethritis, and epididymitis in young people. To stop the spread of chlamydia and lower long-term health risks, screening and teaching are very important.

Why is a correct diagnosis important?

It is very important to get a correct diagnosis of chlamydia because it can lead to major health problems like infertility, chronic pain, pelvic inflammatory disease, and urethritis. Chlamydia that hasn't been diagnosed and treated can spread, which makes it harder to stop and lower the number of people who are infected. To keep chlamydia under control and lessen its effects, public health steps like education and screening are needed.

Pathophysiology of chlamydia infection

Chlamydia trachomatis has two different types of bodies in its life cycle: the basic body (EB) and the reticulate body (RB). The form that binds to and enters host cells is called EB. Once it is inside, it changes into the RB and copies itself in a special pocket called an inclusion.

Chlamydia infects the epithelial cells of the genital system first. The RBs divide and rearrange themselves to become EBs again. These EBs are then sent to attack new cells, which spreads the infection.

Infection and development involve bypassing the host immune system and causing inflammation. This inflammation can damage tissues and leave scars, especially in the reproductive system. This can lead to problems like PID and women not being able to have children.

To come up with good treatments and ways to stop people from getting chlamydia, scientists need to know how this common sexually transmitted infection works. 

What are the signs and problems?

Chlamydia doesn't always show any signs, so it's hard to detect without testing. When signs do show up, they may be different for men and women.

Symptoms that are common in women include vaginal discharge that isn't normal, pain during peeing, and bleeding between periods. Men may have discharge from the penis, a burning feeling when they urinate, and pain and swelling in one or both testicles.

Cases with no symptoms are important because they let the infection grow without being noticed, which raises the risk of transmission and long-term health problems.

If chlamydia is not treated, it can lead to serious problems. It can cause PID in women, which can cause the inability to have children or cause an ectopic pregnancy, in which a fertilised egg implants outside the uterus. In men, problems can include epididymitis, which can also make it hard to get pregnant.

Knowing the signs and possible complications increases the importance of regular screenings and treatment as soon as possible. 

Conventional ways of diagnosing

Tests of culture

In chlamydia culture tests, chlamydia trachomatis bugs are grown in a lab from a sample of the patient's body, usually from the eye, cervix, or urethra. The sample is put in a special solution that helps bacteria grow and is then left to sit for a certain amount of time.

By watching the bacteria grow in the culture medium, pathologists can tell if the bacteria is present. This method only works on live bacteria.

Culture tests, on the other hand, have some problems. Their results often don't show up for several days because they take a lot of time. Furthermore, they need specific lab equipment and are not as sensitive as more recent molecular methods.

Even with these problems, culture tests can be helpful as they let you test for antibiotic susceptibility, which can help you choose the best medicine for treatment. 

Using a microscope

A traditional way to identify chlamydia is to look at a sample under a microscope and see the bacteria directly. The Giemsa stain is a popular way to stain samples. It gives the chlamydia bacteria a colour that lets you see them under a microscope.

Chlamydia infections can be found by looking at inclusion bodies in cells that are infected with the virus under a microscope. It works quickly, but only with skilled technicians, and is not as sensitive as new molecular methods. It works well in places with few resources, but these days it's used in more sensitive ways.

Use of molecular methods to diagnose

Nucleic acid amplification tests

Chlamydia can be diagnosed very accurately with Nucleic Acid Amplification Tests (NAATs). They find DNA material from the bacteria, which is how they work. DNA polymerase chain reaction (PCR), ligase chain reaction (LCR), and transcription-mediated amplification (TMA) are all common types of NAATs.

NAATs are sensitive and effective tests for chlamydia as they can detect even very small amounts of DNA from bacteria. Regular screening with them is suggested for high-risk groups and sexually active people under the age of 25. As they are accurate and flexible, they help with early identification and treatment, which stops the spread of infections.

Gene sequencing

Genetic sequencing is a key part of both research and clinical practice for diagnosing chlamydia. This method helps to understand the genetic diversity and evolution of chlamydia1, which gives information about how it spreads and how to fight it.

In medicine, genetic sequencing helps figure out what kind of germ an organism is, which is useful for epidemiological studies and outbreak investigations. It gives further details about the cell genome, which helps us understand drug resistance. Genetic sequencing is still a useful way to learn more about chlamydia cases and improve treatment, even though it has some problems.

Methods for immunological diagnosis

Enzyme-linked immunosorbent assay (ELISA)

An immune test called ELISA is often used to find chlamydia. It finds antibodies or antigens that are linked to the bacteria in a patient's blood. In this test, the target antigen or antibody is attached to a solid surface, and then an enzyme-linked antibody is used to produce a signal that can be picked up.

Many people use ELISA as it is accurate and sensitive, but it might not be as sensitive as molecular methods and could give false positives.

Rapid diagnostic tests

Some types of rapid diagnostic tests (RDTs) for chlamydia are immunochromatographic tests and lateral flow studies. The results of these tests are available within minutes and can find chlamydial antigens in a patient's blood.

RDTs are useful in the field because they are easy to use, quick, and don't require many tools. However, they might not be as sensitive or specific as the methods used in a lab.

New technologies for diagnosing

Testing at the point of care (POC)

Assays for rapid chlamydia tests that use lateral flow or portable machines are examples of point-of-care (POC) testing. These are medical treatments that are performed close to where the patient is being treated. These tests are easier to obtain and shorten the time between diagnosis and treatment making them great for providing diagnosis in rural areas.

Biosensors and microfluidics

Biosensors and microfluidics are new technologies that make it easier to find biological molecules like chlamydial proteins. These sensitive, specific, and quick diagnostic tools could change how chlamydia is tested by making accurate, portable, and cheap diagnostic tools available all over the world. This would be good for public health.

Comparison of different diagnostic methods

NAATs can detect even very small amounts of chlamydial DNA. Other tests, like culture tests and microscopes, are not as precise. The immune tests, such as ELISA and RDTs, are in the middle, but they are expensive as they use more modern technology. They are simple to use and can be reached from places that are hard to get to, while NAATs and culture tests need special labs. The results come quickly, usually in minutes or hours.

Problems with diagnosing chlamydia

Chlamydia testing is hard because many people don't show any symptoms. This means that infections can go undiagnosed and untreated. False positives and rejections can happen with different kinds of samples and tests. Also, the shame that comes with having an STI, the high cost, and the limited availability of testing centres can slow down the process, make public health problems worse, and increase detection and treatment time.

FAQs

What is the best way to check for chlamydia?

Polymerase chain reaction (PCR), transcription-mediated amplification (TMA), and strand displacement amplification (SDA) are considered to be the best ways to diagnose chlamydia.2

How do they find out if someone has chlamydia?

A test called nucleic acid amplification (NAAT) can determine if someone has chlamydia. For these tests, a sample of body fluid from the throat, cervix, vagina, eyes, rectum, or cervix of the individual is used to detect the DNA of chlamydia bugs. These tests work really well to diagnose chlamydia.3

How bad is chlamydia?

Chlamydia usually doesn't cause any symptoms and can be treated with antibiotics. If it isn't treated, it can get worse and cause long-term health problems, especially in women.4 

Summary

Chlamydia, a sexually transmitted illness, is very dangerous to your health as it doesn't cause any symptoms. If you don't address it, problems like pelvic inflammatory disease, ectopic pregnancies, urethritis, and epididymitis can happen. To avoid infertility and constant pain, it is very important to get the right diagnosis. Common ways of diagnosing, like culture tests, microscopes, and NAATs, are used, but problems like cases with no symptoms still occur.

References

  1. Seth-Smith HMB, Harris SR, Skilton RJ, Radebe FM, Golparian D, Shipitsyna E, et al. Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Research. 2013 Mar 22;23(5):855–66.
  2. Best Practices in Testing Adults and Adolescents for Chlamydia and Gonorrhea in the Emergency Department An Information Paper [Internet]. [cited 2023 May 13]. Available from: https://www.acep.org/siteassets/uploads/uploaded-files/acep/clinical-and-practice-management/policy-statements/information-papers/best-practices-in-testing-adults-and-adolescents-for-chlamydia-and-gonorrhea-in-the-ed.pdf
  3. Canada PHA of. Chlamydia and LGV guide: Key information and resources [Internet]. www.canada.ca. 2021. Available from: https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/chlamydia-lgv.html
  4. NHS. Overview - Chlamydia [Internet]. National Health Service. 2021. Available from: https://www.nhs.uk/conditions/chlamydia/

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative
[optin-monster-inline slug="yw0fgpzdy6fjeb0bbekx"]
This content is purely informational and isn’t medical guidance. It shouldn’t replace professional medical counsel. Always consult your physician regarding treatment risks and benefits. See our editorial standards for more details.

Get our health newsletter

Get daily health and wellness advice from our medical team.
Your privacy is important to us. Any information you provide to this website may be placed by us on our servers. If you do not agree do not provide the information.

Pooja Singh

Masters of Pharmacy (M.Pharm.), Panjab University, Chandigarh (India)

Pooja is a seasoned pharmacovigilance professional with over a decade of experience in the drug safety domain within the pharmaceutical industry and service sectors. She has a comprehensive understanding of pharmacovigilance practices, from both operational and strategic perspectives and has demonstrated a deep commitment to ensuring the safety and efficacy of pharmaceutical products. With a Master of Pharmacy (M.Pharm) degree, her professional journey has been driven by a passion for pharmacovigilance and a dedication to improving public health outcomes.

Throughout her career, she has actively contributed to the development and maintenance of robust pharmacovigilance systems, adhering to global regulatory standards. Her expertise includes adverse event reporting, aggregate report writing, quality management, and signal detection, among other critical aspects of drug safety.

Leave a Reply

Your email address will not be published. Required fields are marked *

my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818
arrow-right